Prieto L

Language: Spanish
References: 20
Page: 95-100
PDF size: 250.82 Kb.

Text Extraction

No abstract

REFERENCES

1. Suji G, Sivakami S. Glucose, glycation and aging. Biogerontology 2004; 5: 365-73.

2. Pageon H, Asselineau D. An in vitro approach to the chronological aging of skin by glyction of the collagen: the biological effect of glycation on the reconstructed skin model. Ann N Y Acads Sci 2005; 1043:529-32.

3. Uribarri J, Cai W, Peppa M et al. Circulating glycotoxins and dietary advanced glycation end products: two links to inflammatory response, axidative stress, and aging. J Gerontol A Biol Sci Med Sci 2007; 62: 427-33.

4. Pageon H, Téccher MP, Asselineau D. Reconstructed skin modified by glycation of the dermal equivalent as a model for skin aging and its potential use to evaluate anti-glycation molecules. Exp Gerontol 2008; 43: 584-8.

5. Hipkiss AR, Michaelis J, Syrris. Non-enzymatic glycosylation of the dipeptide Lcarnosine, a potential anti-protein-crosslinking agent. P FEBS Lett 1995; 371: 81-5.

6. Howard EW, Benton R, Ahern-Moore J et al. Cellular contraction of collagen lattices is inhibited by nonenzymatic glycation. Exp Cell Res 1996; 228: 132.

7. Hipkiss AR, Worthington VC, Himsworth DT et al. Protective effects of carnosine against protein modification mediated by malondialdehyde and hy-pochlorite. Biochim Biophys Acta 1998; 1380: 46-54.

8. Hipkiss AR, Chana H. Carnosine protects proteins against methylglyoxal-mediated modifications. Biochem Biophys Res Commun 1998; 248: 28-32.

9. Hipkiss AR. On the enigma of carnosine’s anti-ageing action. Exp Gerontol 2009; 44: 237-42.

10. Morcos M, Du X, Pfisterer F, Hutter H et al. Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans. Aging Cell 2008; 7: 260-9.

11. Hipkiss AR, Brownson C, Carrier MJ. Carnosine, the anti-ageing, anti-oxidant dipeptide, may react with protein carbonyl groups. Mech Ageing Dev 2001; 122: 1431-45.

12. Quinn PJ, Boldyrev AA, Formazuyk VE. Carnosine: its properties, functions and potential therapeutic applications. Mol Aspects Med 1992; 13: 379-444.

13. Rimbach G, Virgili F, Park YC, Packer L. Effect of procyanidins from Pinus maritima on glutathione levels in endothelial cells challenged by 3-morpholinosydnonimine or activated macrophages. Redox Rep 1999; 4: 171-7.

14. Brenneisen P, Sies H, Scharffetter-Kochanek K. Ultraviolet-B irradiation and matrix metalloproteinases: from induction via signaling to initial events”. Ann N Y Acad Sci 2002; 973: 31-43.

15. Rihn B, Saliou C, Bottin MC et al. From ancient remedies to modern therapeutics: pine bark uses in skin disorders revisited. Phytother Res 2001; 15: 76-8.

16. Halliwell B, Gutteridge JM. The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990; 280: 1-8.

17. Quevedo WC Jr, Holstein TJ, Dyckman J et al. The responses of the human epidermal melanocyte system to chronic erythemal doses of UVR in skin protected by topical applications of a combination of vitamins C and E. Pigment Cell Res 2000; 3: 190-2.

18. Kojo S. Vitamin C: basic metabolism and its function as an index of oxidative stress. Curr Med Chem 2004; 11: 1041-64.

19. Nusgens BV, Humbert P, Rougier A et al. Topically applied vitamin C enhances the mRNA level of collagens I and III, their processing enzymes and tissue inhibitor of matrix metalloproteinase 1 in the human dermis. J Invest Dermatol 2001; 116: 853-9.

20. Boyce ST, Supp AP, Swope VB et al. Vitamin C regulates keratinocyte viability, epidermal barrier, and basement membrane in vitro, and reduces wound contraction after grafting of cultured skin substitutes. J Invest Dermatol 2002; 118: 565-72.